Sumitomo Chemi.

Which are the latest news on Sumitomo Chemi.?

Why is Sumitomo Chemical India Ltd falling/rising?

As of 05-Sep, Sumitomo Chemical India Ltd's stock price is at 493.60, down 1.02% after six days of declines. Despite recent drops, increased delivery volume and strong financial results indicate potential for recovery, though the stock has declined 15.49% over the past year.

As of 05-Sep, Sumitomo Chemical India Ltd's stock price is currently at 493.60, reflecting a decline of 5.1 points or 1.02%. This decrease can be attributed to a recent trend where the stock has experienced six consecutive days of falling prices before showing a slight trend reversal today. Over the past week, the stock has declined by 4.68%, which is significantly worse than the benchmark Sensex's decline of 0.97% during the same period.<BR><BR>Despite the current drop, there are some positive indicators that suggest potential for recovery. The stock's delivery volume increased by 144.83% on September 3, indicating rising investor participation. Additionally, the company has reported strong financial results, with a notable growth in net sales and profit before tax compared to previous quarters, which may support future price stability.<BR><BR>However, the stock's performance over longer periods shows a decline of 15.49% over the past year, contrasting with a year-to-date increase of 4.90%. This mixed performance, along with the current price drop, suggests that while there are positive factors at play, the stock is currently facing downward pressure.

Who are in the management team of Sumitomo Chemi.?

The management team of Sumitomo Chemical includes Mukul G Asher (Chairman), Chetan Shah (Managing Director), and several directors and officers, responsible for the company's operations and strategic direction. Key members also include B V Bhargava, Ninad D Gupta, Preeti Mehta, Sushil Marfatia, Masanori Uzawa, Suresh Ramachandran, and Deepika Trivedi.

The management team of Sumitomo Chemical includes the following members:<BR><BR>1. Mukul G Asher - Chairman & Independent Director<BR>2. Chetan Shah - Managing Director<BR>3. B V Bhargava - Independent Director<BR>4. Ninad D Gupta - Director<BR>5. Preeti Mehta - Independent Director<BR>6. Sushil Marfatia - Executive Director<BR>7. Masanori Uzawa - Director<BR>8. Suresh Ramachandran - Whole-time Director<BR>9. Deepika Trivedi - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What does Sumitomo Chemi. do?

Sumitomo Chemical India Ltd manufactures household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products. As of June 2026, it reported net sales of ₹1,063 Cr and a net profit of ₹215 Cr, with a market cap of ₹25,771 Cr.

Overview: <BR>Sumitomo Chemical India Ltd is engaged in the manufacturing of household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products, operating within the Pesticides & Agrochemicals industry as a small-cap company.<BR><BR>History: <BR>The company was incorporated on 15 February 2000 and transitioned from a Private Limited to a Public Limited company on 24 November 2018. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,063 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 215 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 25,771 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 45.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.25% <BR>Debt-Equity: -0.28 <BR>Return on Equity: 16.37% <BR>Price to Book: 7.63 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Sumitomo Chemi.?

Sumitomo Chemi.'s peers include UPL, P I Industries, Bayer CropSci., Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., and Bharat Rasayan. Management risk varies from excellent to average, with Bhagiradha Chem. showing the highest 1-year return at 8.27%, while Sumitomo Chemi. has a return of -9.16%.

Peers: The peers of Sumitomo Chemi. are UPL, P I Industries, Bayer CropSci., Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., and Bharat Rasayan.<BR><BR>Quality Snapshot: Excellent management risk is observed at P I Industries, Bayer CropSci., and Dhanuka Agritech, while Good management risk is found at UPL, Sumitomo Chemi., and the rest. Average management risk is present at Sharda Cropchem, Rallis India, NACL Industries, Bhagiradha Chem., and Bharat Rasayan. Growth is rated as Good for Sharda Cropchem, while Below Average growth is seen at UPL, P I Industries, Sumitomo Chemi., Bayer CropSci., Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., and Bharat Rasayan. Capital Structure is rated as Excellent for P I Industries, Sumitomo Chemi., Bayer CropSci., Sharda Cropchem, Dhanuka Agritech, Rallis India, and Bharat Rasayan, while Below Average is noted for NACL Industries, and Good for Bhagiradha Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bhagiradha Chem. at 8.27%, while the lowest is Bharat Rasayan at -50.71%. Sumitomo Chemi.'s own 1-year return is -9.16%, which is better than Bharat Rasayan but worse than Bhagiradha Chem. Additionally, peers with negative six-month returns include UPL, P I Industries, Bayer CropSci., Sharda Cropchem, Dhanuka Agritech, Rallis India, and Bharat Rasayan.

How big is Sumitomo Chemi.?

As of 31st August, Sumitomo Chemical India Ltd has a market capitalization of 25,771.00 Cr, with recent net sales of 3,244.89 Cr and a net profit of 579.46 Cr.

As of 31st August, Sumitomo Chemical India Ltd has a market capitalization of 25,771.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 3,244.89 Cr and a Net Profit of 579.46 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, with Shareholder's Funds amounting to 3,389.67 Cr and Total Assets of 4,473.76 Cr.

Should I buy, sell or hold Sumitomo Chemical India Ltd?

Are Sumitomo Chemical India Ltd latest results good or bad?

Sumitomo Chemical India Ltd's latest Q1 FY27 results are strong, with a net profit of ₹214.83 crores, up 93.14% QoQ and 20.46% YoY, alongside a revenue increase of 55.52% QoQ. Overall, the performance reflects effective cost management and operational efficiency, indicating favorable results for the company.

Sumitomo Chemical India Ltd's latest results for Q1 FY27 indicate a strong performance overall. The company reported a net profit of ₹214.83 crores, which represents a remarkable 93.14% increase quarter-on-quarter (QoQ) and a 20.46% rise year-on-year (YoY). This growth reflects the company's ability to capitalize on the peak application season in the agrochemical sector.<BR><BR>Revenue for the quarter stood at ₹1,063.35 crores, showing a substantial 55.52% QoQ increase, although the YoY growth was modest at 0.62%. The operating margin improved to 21.94%, marking a significant expansion of 232 basis points QoQ, and the profit after tax (PAT) margin reached an impressive 20.17%, the highest ever recorded by the company.<BR><BR>The results highlight strong operational efficiency and effective cost management, which have driven profitability despite some challenges in revenue growth. Overall, the financial performance suggests that Sumitomo Chemical India is navigating its market effectively, making the latest results appear quite favorable.

When is the next results date for Sumitomo Chemical India Ltd?

The next results date for Sumitomo Chemical India Ltd is 26 May 2026.

The next results date for Sumitomo Chemical India Ltd is scheduled for 26 May 2026.

Is Sumitomo Chemi. technically bullish or bearish?

As of November 14, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the Sensex.

As of 14 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST and Dow Theory are also indicating bearish trends on the weekly, while the monthly signals are mildly bearish. The stock has underperformed significantly compared to the Sensex over various periods, further supporting the bearish outlook.

How has been the historical performance of Sumitomo Chemi.?

Sumitomo Chemi experienced significant fluctuations in financial performance from March 2019 to March 2025, with net sales and operating income dropping to zero by March 2025, while maintaining a strong asset base and achieving profitability in profit before tax and profit after tax. Despite operational losses, total assets grew from 3,368.71 Cr to 3,963.28 Cr during this period.

Answer:<BR>The historical performance of Sumitomo Chemi shows significant fluctuations in key financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Sumitomo Chemi's net sales peaked at 3,510.97 Cr in March 2023 but dropped to 0.00 Cr by March 2025. The total operating income followed a similar trend, decreasing from 3,510.97 Cr in March 2023 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was 2,844.37 Cr in March 2023 and increased to 2,516.47 Cr in March 2025. Operating profit (PBDIT) showed a decline from 711.45 Cr in March 2023 to -2,516.47 Cr in March 2025, indicating a significant operational loss. Despite this, profit before tax improved from 654.18 Cr in March 2023 to 680.24 Cr in March 2025, while profit after tax also saw an increase from 502.21 Cr to 506.44 Cr in the same period. The company's total assets grew from 3,368.71 Cr in March 2023 to 3,963.28 Cr in March 2025, reflecting a strong asset base despite the operational challenges. Cash flow from operating activities decreased from 757.00 Cr in March 2024 to 452.00 Cr in March 2025, and the net cash outflow was recorded at -8.00 Cr in March 2025. Overall, while Sumitomo Chemi faced operational difficulties leading to losses, it maintained a solid asset position and managed to achieve profitability in terms of tax and net profit.

Who are the top shareholders of the Sumitomo Chemi.?

The top shareholders of Sumitomo Chemical include Sumitomo Chemical Co. Ltd. with 75.0%, mutual funds with 6.27%, foreign institutional investors at 3.63%, HSBC Small Cap Fund as the largest public shareholder at 1.09%, and individual investors holding 10.14%. This indicates a strong promoter presence in the company.

The top shareholders of Sumitomo Chemical include the following:<BR><BR>1. **Promoter with the highest holding**: Sumitomo Chemical Co. Ltd., which holds 75.0% of the shares.<BR>2. **Mutual Funds**: A total of 30 schemes collectively hold 6.27%.<BR>3. **Foreign Institutional Investors (FIIs)**: 131 FIIs hold 3.63%.<BR>4. **Highest Public Shareholder**: HSBC Small Cap Fund, with a holding of 1.09%.<BR>5. **Individual Investors**: They collectively hold 10.14% of the shares.<BR><BR>This distribution highlights a strong promoter presence in the company, particularly from Sumitomo Chemical Co. Ltd.

Is Sumitomo Chemi. overvalued or undervalued?

As of February 14, 2020, Sumitomo Chemical India Ltd. is considered very expensive and overvalued, with a PE ratio of 51.25 and a Price to Book Value of 8.93, despite a strong ROCE of 23.07%, indicating it trades at a premium compared to its peers and has underperformed in longer-term returns.

As of 14 February 2020, the valuation grade for Sumitomo Chemical India Ltd. has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 51.25, a Price to Book Value of 8.93, and an EV to EBITDA of 40.28, all of which suggest that the stock is trading at a premium compared to its earnings and asset values.<BR><BR>In comparison to its peers, Sumitomo Chemical India Ltd. stands out with a PE ratio of 51.25, while its closest competitor has a lower valuation, reinforcing its overvalued status. Additionally, the company's return on capital employed (ROCE) is a strong 23.07%, but this does not offset the high valuation metrics. Notably, while the stock has outperformed the Sensex over the past week and month, it has lagged behind in year-to-date and longer-term returns, further supporting the conclusion that it is overvalued in the current market context.

Has Sumitomo Chemi. declared dividend?

Yes, Sumitomo Chemical India Ltd has declared a 9% dividend (₹0.9 per share) with an ex-date of July 19, 2024. While recent performance shows mixed returns, the company has demonstrated positive growth over the longer term, especially with a total return of 92.31% over the past five years.

Yes, Sumitomo Chemical India Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 9%<BR>- Amount per share: 0.9<BR>- Ex-date: 19 Jul 24<BR><BR>Dividend Yield: 0.17%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -6.03%, with a dividend return of 0%, resulting in a total return of -6.03%.<BR><BR>For the 1-year period, the price return was 8.21%, the dividend return was 0.18%, leading to a total return of 8.39%.<BR><BR>Over the 2-year period, the price return was 25.17%, the dividend return was 1.66%, resulting in a total return of 26.83%.<BR><BR>In the 3-year period, the price return was 7.24%, the dividend return was 1.98%, culminating in a total return of 9.22%.<BR><BR>During the 4-year period, the price return was 45.11%, with a dividend return of 2.30%, giving a total return of 47.41%.<BR><BR>For the 5-year period, the price return was 88.86%, the dividend return was 3.45%, resulting in a total return of 92.31%.<BR><BR>Overall, Sumitomo Chemical India Ltd has declared a dividend, and while the recent performance shows mixed returns, the longer-term trends indicate positive growth, particularly over the 5-year period.